Anti-ELK1 antibody [E277]
- RabMAb
- Recombinant
- KO Validated
- Advanced Validation
- What is this?
Be the first to review this product! Submit a review
|
(57 Publications)
Rabbit Recombinant Monoclonal ELK1 antibody. Suitable for ChIC/CUT&RUN-seq, IHC-P, WB, ICC/IF, Flow Cyt (Intra) and reacts with Human samples. Cited in 57 publications.
View Alternative Names
ETS domain-containing protein Elk-1, ELK1
- ICC/IF
Lab
Immunocytochemistry/ Immunofluorescence - Anti-ELK1 antibody [E277] (AB32106)
Immunocytochemistry/ Immunofluorescence analysis of A549 (human lung carcinoma epithelial cell) cells labeling ELK1 with purified ab32106 at 1/500 dilution (3.8 μg/mL). Cells were fixed in 4% Paraformaldehyde and permeabilized with 0.1% tritonX-100. Goat anti rabbit IgG (Alexa Fluor® 488, ab150077) was used as the secondary antibody at 1/1000 (2 μg/mL) dilution. DAPI (blue) was used as nuclear counterstain.
- Flow Cyt (Intra)
Unknown
Flow Cytometry (Intracellular) - Anti-ELK1 antibody [E277] (AB32106)
Intracellular Flow Cytometry analysis of HeLa (human cervix adenocarcinoma) cells labeling ELK1 with unpurified ab32106 at 1/20 dilution (10ug/mL) (red). Cells were fixed with 4% paraformaldehyde and permeabilised with 90% methanol. A Goat anti rabbit IgG (Alexa Fluorr® 488) at 1/2000 dilution was used as the secondary antibody. Rabbit monoclonal IgG (Black) was used as the isotype control, cells without incubation with primary antibody and secondary antibody (Blue) were used as the unlabeled control.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-ELK1 antibody [E277] (AB32106)
Immunohistochemical analysis of paraffin embedded human breast carcinoma using ab32106 at a dilution of 1/50
Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.
- WB
Lab
Western blot - Anti-ELK1 antibody [E277] (AB32106)
Lane 1 : Wild-type HAP1 whole cell lysate (20 μg)
Lane 2 : ELK1 knockout HAP1 whole cell lysate (20 μg)
Lane 3 : HeLa positive whole cell lysate (21 μg)
Lane 4 : MCF7 negative whole cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab32106 observed at 55 kDa. Red - loading control, ab18058, observed at 130 kDa.
ab32106 was shown to specifically react with ELK1 in wild-type HAP1 cells as signal was lost in ELK1 knockout cells. Wild-type and ELK1 knockout samples were subjected to SDS-PAGE. ab32106 and ab18058 (Mouse anti-Vinculin loading control) were incubated overnight at 4°C at 1/500 dilution and 1/20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed ab216773 and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed ab216776 secondary antibodies at 1/10000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-ELK1 antibody [E277] (ab32106)
Predicted band size: 45 kDa
false
- WB
Lab
Western blot - Anti-ELK1 antibody [E277] (AB32106)
Lanes 1- 2 : Merged signal (red and green). Green - ab32106 observed at 55 kDa. Red - Anti-GAPDH antibody [6C5] - Loading Control (ab8245) observed at 37 kDa.
ab32106 was shown to react with ELK1 in wild-type HeLa cells in western blot. Loss of signal was observed when knockout cell line ab261764 (knockout cell lysate ab256904) was used. Wild-type HeLa and ELK1 knockout HeLa cell lysates were subjected to SDS-PAGE. Membrane was blocked for 1 hour at room temperature in 0.1% TBST with 3% non-fat dried milk. ab32106 and Anti-GAPDH antibody [6C5] - Loading Control (ab8245) overnight at 4°C at a 1 in 500 dilution and a 1 in 20000 dilution respectively. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye®800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye®680RD) preadsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-ELK1 antibody [E277] (ab32106) at 1/500 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
ELK1 knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human ELK1 knockout HeLa cell line (<a href='/en-us/products/cell-lines/human-elk1-knockout-hela-cell-line-ab261764'>ab261764</a>)
Predicted band size: 45 kDa
Observed band size: 55 kDa
false
- ChIC/CUT&RUN-seq
Supplier Data
ChIC/CUT&RUN sequencing - Anti-ELK1 antibody [E277] (AB32106)
CUT&RUN profiling with ELK1 antibody demonstrates robust genome-wide enrichment in cells. Heatmaps of genome-wide signal flanking annotated transcription start sites (TSSs, +/- 2 kbp) display CUT&RUN data generated using the CUTANA™ CUT&RUN Kit (EpiCypher 14-1048) with ELK1 antibody (Abcam ab32106, 0.5 µg). 500,000 HeLa cells were used per reaction. IgG antibody was included as a negative control to assess non-specific background. Libraries were prepared using the CUTANA™ CUT&RUN Library Prep Kit (EpiCypher 14-1001). Sequencing was performed with paired-end 50 bp reads, and data were processed on CUTANA™ Cloud (cloud.epicypher.com) by alignment to the hg38 genome. Heatmaps were generated using ChAsE (Younesy et al., Bioinformatics 2016; PMID 27378294). Row-linked data are ranked by intensity relative to ELK1, with red indicating high localized enrichment and blue denoting background.
- ChIC/CUT&RUN-seq
Supplier Data
ChIC/CUT&RUN sequencing - Anti-ELK1 antibody [E277] (AB32106)
CUT&RUN profiling with ELK1 antibody reveals the expected genomic enrichment pattern in cells. Representative genome browser tracks show CUT&RUN data generated using the CUTANA™ CUT&RUN Kit (EpiCypher 14-1048) with ELK1 antibody (Abcam ab32106, 0.5 µg). 500,000 HeLa cells were used per reaction. IgG, H3K4me3, and H3K27me3 antibodies were included as controls to assess non-specific background, active promoters, and repressed chromatin, respectively. Libraries were prepared using the CUTANA™ CUT&RUN Library Prep Kit (EpiCypher 14-1001). Sequencing was performed with paired-end 50 bp reads, and data were processed on CUTANA™ Cloud (cloud.epicypher.com) by alignment to the hg38 genome. Images were generated using Integrative Genomics Viewer (IGV, Broad Institute).
- WB
Unknown
Western blot - Anti-ELK1 antibody [E277] (AB32106)
All lanes:
Western blot - Anti-ELK1 antibody [E277] (ab32106) at 1/500 dilution
Predicted band size: 45 kDa
Observed band size: 62 kDa
false
Related conjugates and formulations (2)
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-ELK1 antibody [E277]
-
Anti-ELK1 antibody [E277] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
ELK1 functions in the regulation of gene expression related to cellular proliferation and differentiation. It often forms a ternary complex with serum response factor (SRF) on serum response elements (SREs) to modulate the transcriptional responses of genes important for cell growth. The activation of ELK1 is phosphorylation-dependent primarily by mitogen-activated protein kinases (MAPKs) which further facilitates its role as a transcription regulator. This phosphorylation increases the transcriptional activity enabling ELK1 to actively participate in cellular responses to external signals.
Pathways
ELK1 participates prominently in the MAPK/ERK signaling pathway and the JNK signaling pathway. Through these pathways ELK1 gets activated influencing the transcription of immediate early genes responsible for cell cycle progression and apoptosis. ELK1 interacts with other proteins in these pathways such as MEK and ERK leading to a coordinated response to growth signals. These interactions underline its importance in signal transduction processes and cellular response mechanisms.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (57)
Recent publications for all applications. Explore the full list and refine your search
Clinical epigenetics 17:146 PubMed40886022
2025
Applications
Unspecified application
Species
Unspecified reactive species
Experimental & molecular medicine 57:1032-1046 PubMed40307574
2025
Applications
Unspecified application
Species
Unspecified reactive species
Annals of medicine 56:2424515 PubMed39529543
2024
Applications
Unspecified application
Species
Unspecified reactive species
Annals of medicine and surgery (2012) 86:5767-5775 PubMed39359848
2024
Applications
Unspecified application
Species
Unspecified reactive species
Cell proliferation 57:e13635 PubMed38594962
2024
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 25: PubMed38397056
2024
Applications
Unspecified application
Species
Unspecified reactive species
iScience 26:107143 PubMed37456852
2023
Applications
Unspecified application
Species
Unspecified reactive species
Journal of traditional and complementary medicine 13:600-610 PubMed38020551
2023
Applications
Unspecified application
Species
Unspecified reactive species
Protein expression and purification 203:106216 PubMed36528218
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell cycle (Georgetown, Tex.) 22:117-130 PubMed35941836
2022
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com